Diacylglycerol oil for the metabolic syndrome

doi:10.1186/1475-2891-6-43

Nutrition Journal

Volume 6

Viewing options:

Abstract
Full text
PDF (506KB)

Associated material:

Related literature:

Articles citing this article
on Google Scholar
on PubMed Central
Other articles by authors
on Google Scholar

Yanai H
Tomono Y
Ito K
Furutani N
Yoshida H
Tada N

on PubMed

Yanai H
Tomono Y
Ito K
Furutani N
Yoshida H
Tada N
Related articles/pages
on Google

on Google Scholar

on PubMed

Tools:

Post to:

Review

Diacylglycerol oil for the metabolic syndrome

Hidekatsu Yanai¹ , Yoshiharu Tomono¹ , Kumie Ito¹ , Nobuyuki Furutani¹ , Hiroshi Yoshida² and Norio Tada¹

¹Department of Internal Medicine, The Jikei University School of Medicine, Chiba, Japan

²Department of Laboratory Medicine, The Jikei University School of Medicine, Chiba, Japan

author email corresponding author email

Nutrition Journal 2007, 6:43doi:10.1186/1475-2891-6-43


Published:	11 December 2007

Abstract

Excess adiposity has been shown to play a crucial role in the development of the metabolic syndrome. The elevated fasting and postprandial triglyceride-rich lipoprotein levels is the central lipid abnormality observed in the metabolic syndrome. Recent studies have indicated that diacylglycerol (DAG) is effective for fasting and postprandial hyperlipidemia and preventing excess adiposity by increasing postprandial energy expenditure. We will here discuss the mechanisms of DAG-mediated improvements in hyperlipidemia and in postprandial energy expenditure, and effects of DAG oil on lipid/glucose metabolism and on body fat. Further, the therapeutic application of DAG for the metabolic syndrome will be considered.